Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T22:25:25.020Z Has data issue: false hasContentIssue false
  • English
  • Français

Seroepidemiological study of HBV infections in Athens, Greece

Published online by Cambridge University Press:  15 May 2009

G. Papaevangelou ,
A. Kyriakidou ,
C. Vissoulis  and
D. Trichopoulos
G. Papaevangelou
Affiliation:
Department of Hygiene and Epidemiology, University of Athens
A. Kyriakidou
Affiliation:
Department of Hygiene and Epidemiology, University of Athens
C. Vissoulis
Affiliation:
Department of Hygiene and Epidemiology, University of Athens
D. Trichopoulos
Affiliation:
Department of Hygiene and Epidemiology, University of Athens
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A seroepidemiological survey of a sample – roughly representative by age and sex – of 2744 persons of the Greater Athens area revealed that hepatitis B virus (HBV) infections are highly endemic in Greece. Hepatitis B surface antigen (HBsAg) was detected in 72 (2·6 %) of them. The subtype was identified in 70 of the 72 carriers, and 69 were ay; the other was ad. Determinant w was present in all 61 that were capable of being typed further, and a23y(w) was twice as common as a11y(w). Antibody to HBsAg (anti-HBs) was found in 514 (18·7%) persons. The prevalence of the HBsAg rose rapidly with age, reaching peak values (5·3%) at 20–29 years, while anti-HBs reached its highest value (42·1%) in older age groups (50–59 years). The frequency of HBsAg was significantly higher in males (3·4%) than in females (1·5%). The percentage of infected persons who become chronic HBsAg carriers (12·3%) was found higher than in other developed populations. It was also found higher in children (25%) than in adults (5·5%) and in males (14·6%) than in females (8·1%). These data indicate that HBV infection in early life is a major risk factor in the development of HBsAg carriers and support the hypothesis that males are more likely to become HBsAg carriers than females.

Type
Research Article
Information
Journal of Hygiene , Volume 76 , Issue 2 , April 1976 , pp. 229 - 234
Copyright
Copyright © Cambridge University Press 1976

References

REFERENCES

Bancroft, W. H., Mundon, F. M. & Russel, P. K. (1972). Detection of additional antigenic determinants of hepatitis B antigen. Journal of Immunology 109, 842.Google Scholar
Blumberg, B. S., Sutnick, A. I., London, W. T. & Melartin, L. (1972). Sex distribution of Australia antigen. Archives of Internal Medicine 130, 227.CrossRefGoogle ScholarPubMed
Cherubin, C. E., Purcell, R. H., Lander, J. J., McGinn, I. G. & Cone, L. A. (1972). Acquisition of antibody to hepatitis B antigen in three socio-economically different medical populations. Lancet ii, 149.Google Scholar
Gerety, R. J., Hoofnagle, J. H., Markenson, L. A. & Barker, L. F. (1974). Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children. Journal of Pediatrics 84, 661.Google Scholar
Grossman, R. A., Benenson, M. W., Scott, R. M., Snitbhau, R., Top, F. H., Pantuwatana, S. (1975). An epidemiologic study of hepatitis B virus in Bangkok, Thailand. American Journal of Epidemiology 101, 144.CrossRefGoogle ScholarPubMed
Hadziyannis, S. J. (1974). Chronic viral hepatitis. Clinics in Gastroenterology 3, 391.Google Scholar
Hadziyannis, S. J. & LeBouvier, G. L. (1972). Australia antigen subtypes in Greece. Iatriki 22, 453.Google Scholar
Krugman, S. & Giles, J. P. (1973). Viral hepatitis, type B (MS-2-strain): natural history and prevention. New England Journal of Medicine 228, 755.Google Scholar
LeBouvier, G. L. (1971). The heterogeneity of Australia antigen. Journal of Infectious Diseases 123, 671.CrossRefGoogle Scholar
LeBouvier, G. L. & McCollum, R. W. (1970). Australia (hepatitis-associated) antigen: physicochemical and immunological characteristics. Advances in Virus Research 16, 357.Google Scholar
Mazzur, S., Burgert, S. & Blumberg, B. S. (1974). Geographical distribution of Australia antigen determinants d, y and w. Nature, London 247, 38.CrossRefGoogle Scholar
Mosley, J. W., Edwards, W. M., Meilhaus, J. E. & Redecker, A. G. (1972). Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. American Journal of Epidemiology 95, 529.Google ScholarPubMed
Papaevangelou, G., Vissoulis, C., Kremastinou, T. & Trichopoulos, D. (1974). Prevalence of hepatitis B infections among young Greeks. Minerva Medica Greca 2, 259.Google Scholar
Pesendorfer, F., Krassnitzky, O. & Wewalka, F. (1970). Immunoelektrophoretischer Nachweis von 'Hepatitis-associated Antigen' (Au/SH Antigen). Klinische Wochenschrift 48, 58.Google Scholar
Sherlock, S., Fox, A., Niazi, P. & Scheuer, J. (1970). Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet i, 1243.CrossRefGoogle Scholar
Szmuness, W., Prince, A. M., Diebolt, G., Lebland, L., Baylet, R., Masseyeff, R. & Linhard, J. (1973). The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal. American Journal of Epidemiology 98, 104.Google Scholar
Szmuness, W., Hirsch, R., Prince, A., Levine, R., Harley, J. & Ikram, H. (1975). Hepatitis B surface antigen in blood donors: further observations. Journal of Infectious Diseases 131, 111.CrossRefGoogle ScholarPubMed
Vissoulis, C. & Papaevangelou, G. (1973). Prevalence of hepatitis B antigen. Journal of Infectious Diseases 128, 807.CrossRefGoogle ScholarPubMed
World Health Organization (1973). Viral hepatitis. Technical Report Series no. 512.Google Scholar